Peak6 Investments LLC Vertex Pharmaceuticals Inc Call Options Transaction History

Peak6 Investments LLC

$37.5 Billion
Q2 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $3.1 Million - $3.84 Million	7,900 New	7,900 $3.7 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $960,400 - $1.15 Million	2,800 Added 147.37%	4,700 $1.91 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $101,454 - $108,738	-300 Reduced 13.64%	1,900 $660,000
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $7.04 Million - $7.88 Million	-22,400 Reduced 91.06%	2,200 $774,000
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $4.59 Million - $5.23 Million	16,200 Added 192.86%	24,600 $7.75 Million
Q4 2022 Feb 10, 2023	SELL	$285.76 - $321.48 $1.54 Million - $1.74 Million	-5,400 Reduced 39.13%	8,400 $2.43 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $12.5 Million - $14 Million	-45,700 Reduced 76.81%	13,800 $4 Million
Q2 2022 Aug 12, 2022	BUY	$234.96 - $292.55 $13.9 Million - $17.3 Million	59,200 Added 19733.33%	59,500 $16.8 Million
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $3.21 Million - $3.78 Million	-14,500 Reduced 97.97%	300 $78,000
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $36 Million - $40.3 Million	-198,400 Reduced 93.06%	14,800 $2.69 Million
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $31.9 Million - $37.7 Million	170,300 Added 396.97%	213,200 $43 Million
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $1.97 Million - $2.29 Million	9,500 Added 28.44%	42,900 $9.22 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $1.39 Million - $1.85 Million	6,700 Added 25.09%	33,400 $7.89 Million
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $4.55 Million - $5.4 Million	-17,800 Reduced 40.0%	26,700 $7.27 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $7.22 Million - $9.47 Million	-32,000 Reduced 41.83%	44,500 $12.9 Million
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $12.1 Million - $15.1 Million	60,800 Added 387.26%	76,500 $18.2 Million
Q4 2019 Feb 13, 2020	SELL	$166.71 - $223.91 $7.95 Million - $10.7 Million	-47,700 Reduced 75.24%	15,700 $3.44 Million
Q3 2019 Nov 08, 2019	SELL	$166.23 - $187.09 $5.3 Million - $5.97 Million	-31,900 Reduced 33.47%	63,400 $10.7 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $4.61 Million - $5.33 Million	28,000 Added 41.6%	95,300 $17.5 Million
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $6.04 Million - $7.18 Million	-36,900 Reduced 35.41%	67,300 $12.4 Million
Q4 2018 Feb 13, 2019	BUY	$151.91 - $192.21 $2.08 Million - $2.63 Million	13,700 Added 15.14%	104,200 $17.3 Million
Q3 2018 Nov 13, 2018	BUY	$167.73 - $192.74 $15.2 Million - $17.4 Million	90,500 New	90,500 $17.4 Million

Others Institutions Holding VRTX

# of Institutions

1,717

Shares Held

226M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.5 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.88 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.28 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Account